Insider · CIK 0001293630

Santel Donald J

Reports to the SEC for 6 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001293630

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-01-02	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,889 sh	$13.49	+$39K	2,889
2023-06-06	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-01-19	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-01-19	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,519 sh	$15.48	+$39K	2,519
2023-01-03	Oyster Point Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,489 sh	—	—	8,198
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,198 sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.2K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,359 sh	—	—	0
2022-06-06	Oyster Point Pharma, Inc.A Award	Director	AAward	+3,573 sh	—	—	13,687
2022-06-06	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,359 sh	—	—	5,359
2021-08-11	SRZNSurrozen, Inc./DEA Award	Former Director	AAward	+30K sh	—	—	30,000
2021-08-11	SRZNSurrozen, Inc./DE · Class B Ordinary SharesD Disposition to Issuer	Former Director	DDisposition to Issuer	−30K sh	—	—	0
2021-07-30	Oyster Point Pharma, Inc.A Award	Director	AAward	+6,937 sh	—	—	6,937
2021-07-30	Oyster Point Pharma, Inc.A Award	Director	AAward	+3,177 sh	—	—	10,114
2021-07-30	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10.4K sh	—	—	10,405
2021-07-30	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+4,765 sh	—	—	4,765
2015-05-07	HYPERION THERAPEUTICS INCU Disposition from Tender	Director, CEO & President	UDisposition from Tender	−2,306 sh	$46.00	−$106K	0
2015-05-07	HYPERION THERAPEUTICS INCU Disposition from Tender	Director, CEO & President	UDisposition from Tender	−10.2K sh	$46.00	−$468K	0
2015-05-07	HYPERION THERAPEUTICS INCD Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−53.9K sh	$46.00	−$2.48M	0
2015-05-07	HYPERION THERAPEUTICS INCD Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−292K sh	$46.00	−$13.4M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−303K sh	$46.00	−$13.9M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−6,648 sh	$46.00	−$306K	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−88.5K sh	$46.00	−$4.07M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−143K sh	$46.00	−$6.58M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−111K sh	$46.00	−$5.11M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−70K sh	$46.00	−$3.22M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−169 sh	—	—	0
2015-05-01	HYPERION THERAPEUTICS INCM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+224K sh	$1.28	+$287K	280,689
2015-05-01	HYPERION THERAPEUTICS INCM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+33.2K sh	$4.08	+$136K	313,931
2015-05-01	HYPERION THERAPEUTICS INCM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+34.6K sh	$7.31	+$253K	348,535
2015-05-01	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−224K sh	—	—	303,133
2015-05-01	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−33.2K sh	—	—	6,648
2015-05-01	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−34.6K sh	—	—	88,547
2015-02-09	HYPERION THERAPEUTICS INCA Award	Director, CEO & President	AAward	+40K sh	—	—	56,478
2015-02-09	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)A Award	Director, CEO & President	AAward	+70K sh	—	—	70,000
2015-01-02	HYPERION THERAPEUTICS INCF Tax Payment	Director, CEO & President	FTax Payment	−2,022 sh	$24.28	−$49.1K	16,478
2014-03-11	HYPERION THERAPEUTICS INCA Award	Director, CEO & President	AAward	+18.5K sh	—	—	18,500
2014-03-11	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)A Award	Director, CEO & President	AAward	+111K sh	—	—	111,000
2013-04-15	HYPERION THERAPEUTICS INCStock Option (right to buy)A Award	Director, CEO & President	AAward	+143K sh	—	—	143,000
2011-06-30	Anthera Pharmaceuticals IncStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2010-09-30	Anthera Pharmaceuticals IncStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2006-06-30	COTHERIX INCStock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+150K sh	—	—	150,000
2005-03-11	COTHERIX INCStock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+12K sh	—	—	12,048
2005-03-11	COTHERIX INCStock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+188K sh	—	—	187,952

Recent filings

Accepted (ET)
Jun 74
Santel Donald J0001415889-24-016058
SEC(opens sec.gov)
Jan 44
Santel Donald J0001415889-24-000706
SEC(opens sec.gov)
Jun 84
Santel Donald J0001415889-23-009447
SEC(opens sec.gov)
Jan 234
Santel Donald J0001415889-23-001334
SEC(opens sec.gov)
Jan 44
Santel Donald J0001209191-23-001092
SEC(opens sec.gov)
Jun 84
Santel Donald J0001209191-22-035055
SEC(opens sec.gov)
Aug 134
Santel Donald J0000899243-21-033041
SEC(opens sec.gov)
Aug 34
Santel Donald J0001209191-21-049492
SEC(opens sec.gov)
May 84
HYPERION THERAPEUTICS INC0001209191-15-040806
SEC(opens sec.gov)

Companies

Address

C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B

HAYWARD, CA, 94545